IDT.ASX: Upgrade to FY26 Guidance

Upgrade to FY26 Guidance

Stock	IDT Australia Ltd (IDT.ASX)
Release Time	21 Jul 2026, 2:18 p.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

IDT Australia Ltd FY26 Guidance Upgrade

Key Points

FY26 revenue expected to increase by 16.5% YoY to $16.8M
EBITDA to improve significantly to -$943K
Strong demand and cost savings ahead of target
Recognition from IMAPAC with two prestigious awards

Full Summary

IDT Australia Ltd (ASX:IDT) has announced an upgrade to its revenue and profit guidance for the financial year 2026 (FY26), reflecting favorable trading conditions and strong operational performance. The company now expects unaudited FY26 revenue from its three verticals to increase by 16.5% year-on-year (YoY) to $16.8 million and for unaudited earnings before interest, tax, depreciation, and amortization (EBITDA) to improve significantly to -$943K (vs. FY25: -$6.3M). The drivers behind the guidance upgrade include strong local and international demand momentum for IDT's world-class facilities and end-to-end drug manufacturing services, as well as cost savings running ahead of target. IDT will provide further details and outlook when it releases its full year results and audited accounts next month.

Guidance

IDT Australia Ltd expects FY26 revenue of $16.8M and EBITDA of -$943K

Outlook

IDT Australia Ltd expects to provide further details and outlook when it releases its full year results and audited accounts next month.